A cyclophosphamide-induced autoimmune diabetes

Lancet

Volumn 352, Issue 9125, 1998, Pages 373-374

  Atlan Gepner, C ^a   Bouabdallah, R ^b   Valero, R ^b   Coso, D ^b   Vialettes, B ^b  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOSE; HLA DR ANTIGEN; INSULIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0032145651     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60474-6     Document Type: Article

References (5)

1. 1 Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997; 7: 727-38.
2. 2 Lampeter EF, McCann SR, Kolb H. Transfer of diabetes type 1 by bone-marrow transplantation. Lancet 1997; 351: 568-69.
3. 3 Yasunami R, Bach J-F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 1988; 18: 481-84.
4. 4 Charlton B, Bacelj A, Slattery RM, Mandel TE. Cyclophosphamide-induced diabetes in NOD/Wehi mice: evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 1989; 38: 441-47.
5. 5 Rothe H, Jenkins NA, Copeland NG, Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 1997; 99: 469-74.